Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin

Journal of Infectious Diseases

Volumn 174, Issue 6, 1996, Pages 1356-1360

  Van Der Poll, Tom ^b   Coyle, Susette M ^b   Moldawer, Lyle L ^b   Lowry, Stephen F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOLOGICAL TOLERANCE; LEUKOPENIA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SEPSIS;

EID: 0029807850     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.6.1356     Document Type: Article

References (14)

1. Beeson PB. Tolerance to bacterial pyrogen. J Exp Med 1947;86:29-8.
2. Munoz C, Carlet J, Fitting C, Misset B, Blériot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-54.
3. Van Deuren M, Van der Ven-Jongekrijg J, Demacker PNM, et al. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994;169:157-61.
4. Keuter M, Dharmana E, Hussein Gasem M, et al. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994;169:1306-11.
5. Ertel W, Kremer JP, Kenney J, et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995;85:1341-7.
6. Rodrick ML, Moss NM, Grbic JT, et al. Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans. J Clin Immunol 1992;12:440-9.
7. Granowitz EV, Porat R, Mier JW, et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 1993;151:1637-45.
8. Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor a and potentiates interleukin 10 release during human endotoxemia. J Clin Invest 1996;97:713-9.
9. Kenney JS, Masada MP, Eugui EM, Delustro BM, Mulkins MA, Allison AC. Monoclonal antibodies to human recombinant interleukin 1 (IL-1) beta: quantitation of IL-1 beta and inhibition of biological activity. J Immunol 1987;138:4236-42.
10. Helle M, Boeije L, de Groot ER, de Vos A, Aarden LA. Sensitive ELISA for interleukin 6. Detection of IL-6 in biological fluids and sera. J Immunol Methods 1991;138:47-56.
11. Pruitt JH, Welborn MB, Edwards PD, et al. Increased soluble interleukin 1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 1996;87:3282-8.
12. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-6.
13. Haskill S, Johnson C, Eierman D, Becker S, Warren K. Adherence induces selective mRNA expression of monocyte mediators and protooncogenes. J Immunol 1988;140:1690-4.
14. Randow F, Syrbe U, Meisel C, et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J Exp Med 1995;181:1887-92.